IT ATC N06DA02 · updated 2 Nov 2026
Donepezil shortage in Italy
Is there a Donepezil shortage in Italy?
Yes. As of 2 Nov 2026, 8 Donepezil products are reported short in Italy, the first since 19 Oct 2023. The company estimate for the return is 15 Nov 2026. Main reason: manufacturing problem.
Also short in Canada, Spain, Ireland, Belgium, Czechia, Sweden, Australia. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | DONEPEZIL SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 19 Oct 2023 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | DONEPEZIL MYLAN GENERICS ITALIA | MYLAN S.P.A. | 26 Jan 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | DONEPEZIL ACCORD | ACCORD HEALTHCARE, S.L.U. | 11 Feb 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | DONEPEZIL ACCORD | ACCORD HEALTHCARE, S.L.U. | 22 Mar 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | YASNORO | KRKA D.D. NOVO MESTO | 27 May 2026 | not given | Increased demand Elevata richiesta |
| IT | DONEPEZIL MYLAN GENERICS | MYLAN S.P.A. | 15 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | DONEPEZIL TEVA | TEVA ITALIA S.R.L. | 7 Sep 2026 | 15 Nov 2026 | Manufacturing problem Problemi produttivi |
| IT | DONEPEZIL MYLAN GENERICS ITALIA | MYLAN S.P.A. | 10 Sep 2026 | not given | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.